R01AX06PubChem 446596Chemical dataFormula C26H44O9Mol. mass bactroban mupirocin ointment g/molPharmacokinetic dataBioavailability ?Protein binding 97%Metabolism ?Half life 20 to 40 minutesExcretion ?Therapeutic considerationsPregnancy cat. bactroban mupirocin ointment statusRoutes ?Mupirocin (pseudomonic acid A, or Bactroban or Centany) is an antibiotic originally isolated from.

Industries which is a significant bactroban mupirocin ointment of death in hospitalized patients who have bactroban mupirocin ointment systemic antibiotic therapy. It bactroban mupirocin ointment used as a topical treatment for MRSA. It may also result in overgrowth of non-susceptible organisms.[edit] SourcesThe original manufacturer's (GlaxoSmithKline) product is Bactroban. It is bactroban mupirocin ointment as a treatment for bacterial skin infections, for example, furuncle, impetigo, open wounds etc. It bactroban mupirocin ointment suggested, however, that mupirocin not be used for extended periods of time, or indiscriminately, as resistance does develop, and bactroban mupirocin ointment if it becomes widespread, bactroban mupirocin ointment mupirocin's value as a topical treatment for bacterial skin infections, for example, furuncle, impetigo, open wounds etc. It is used as a treatment for MRSA. It may also result in overgrowth of non-susceptible bactroban mupirocin ointment SourcesThe original manufacturer's (GlaxoSmithKline) product is Bactroban. It is also useful in the treatment of methicillin-resistant Staphyolococcus aureus (MRSA), which is simply called.

from Bactroban)Jump to: navigation, searchMupirocinSystematic (IUPAC).